The global market for Drug-eluting Coronary Stents was estimated to be worth US$ 1745.6 million in 2023 and is forecast to a readjusted size of US$ 2363.2 million by 2030 with a CAGR of 4.2% during the forecast period 2024-2030

Drug-eluting Coronary Stents - Market

Drug-eluting Coronary Stents which is coated with medication that reduces the risk of the artery becoming blocked again

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug-eluting Coronary Stents, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Drug-eluting Coronary Stents by region & country, by Type, and by Application.

The Drug-eluting Coronary Stents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug-eluting Coronary Stents.

Market Segmentation

Scope of Drug-eluting Coronary Stents - Market Report

Report Metric	Details
Report Name	Drug-eluting Coronary Stents - Market
Forecasted market size in 2030	US$ 2363.2 million
CAGR	4.2%
Forecasted years	2024 - 2030
Segment by Type:	Stent Diameter ＜4mm Stent Diameter ＞4mm
Segment by Application	ASCs Hospitals Cardiology Center Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Medtronic, Boston Scientific, Biosensors, Terumo, MicroPort, Lepu Medical, B.Braun, Atrium Medical, SINOMED, LBC, Essen Technology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Drug-eluting Coronary Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Drug-eluting Coronary Stents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Drug-eluting Coronary Stents in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Drug-eluting Coronary Stents - Market size in 2030?

Ans: The Drug-eluting Coronary Stents - Market size in 2030 will be US$ 2363.2 million.

Who are the main players in the Drug-eluting Coronary Stents - Market report?

Ans: The main players in the Drug-eluting Coronary Stents - Market are Medtronic, Boston Scientific, Biosensors, Terumo, MicroPort, Lepu Medical, B.Braun, Atrium Medical, SINOMED, LBC, Essen Technology

What are the Application segmentation covered in the Drug-eluting Coronary Stents - Market report?

Ans: The Applications covered in the Drug-eluting Coronary Stents - Market report are ASCs, Hospitals, Cardiology Center, Others

What are the Type segmentation covered in the Drug-eluting Coronary Stents - Market report?

Ans: The Types covered in the Drug-eluting Coronary Stents - Market report are Stent Diameter ＜4mm, Stent Diameter ＞4mm

1 Market Overview

1.1 Drug-eluting Coronary Stents Product Introduction

1.2 Global Drug-eluting Coronary Stents Market Size Forecast

1.2.1 Global Drug-eluting Coronary Stents Sales Value (2019-2030)

1.2.2 Global Drug-eluting Coronary Stents Sales Volume (2019-2030)

1.2.3 Global Drug-eluting Coronary Stents Sales Price (2019-2030)

1.3 Drug-eluting Coronary Stents Market Trends & Drivers

1.3.1 Drug-eluting Coronary Stents Industry Trends

1.3.2 Drug-eluting Coronary Stents Market Drivers & Opportunity

1.3.3 Drug-eluting Coronary Stents Market Challenges

1.3.4 Drug-eluting Coronary Stents Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Drug-eluting Coronary Stents Players Revenue Ranking (2023)

2.2 Global Drug-eluting Coronary Stents Revenue by Company (2019-2024)

2.3 Global Drug-eluting Coronary Stents Players Sales Volume Ranking (2023)

2.4 Global Drug-eluting Coronary Stents Sales Volume by Company Players (2019-2024)

2.5 Global Drug-eluting Coronary Stents Average Price by Company (2019-2024)

2.6 Key Manufacturers Drug-eluting Coronary Stents Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Drug-eluting Coronary Stents Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Drug-eluting Coronary Stents

2.9 Drug-eluting Coronary Stents Market Competitive Analysis

2.9.1 Drug-eluting Coronary Stents Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Drug-eluting Coronary Stents Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-eluting Coronary Stents as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Stent Diameter ＜4mm

3.1.2 Stent Diameter ＞4mm

3.2 Global Drug-eluting Coronary Stents Sales Value by Type

3.2.1 Global Drug-eluting Coronary Stents Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Drug-eluting Coronary Stents Sales Value, by Type (2019-2030)

3.2.3 Global Drug-eluting Coronary Stents Sales Value, by Type (%) (2019-2030)

3.3 Global Drug-eluting Coronary Stents Sales Volume by Type

3.3.1 Global Drug-eluting Coronary Stents Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Drug-eluting Coronary Stents Sales Volume, by Type (2019-2030)

3.3.3 Global Drug-eluting Coronary Stents Sales Volume, by Type (%) (2019-2030)

3.4 Global Drug-eluting Coronary Stents Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 ASCs

4.1.2 Hospitals

4.1.3 Cardiology Center

4.1.4 Others

4.2 Global Drug-eluting Coronary Stents Sales Value by Application

4.2.1 Global Drug-eluting Coronary Stents Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Drug-eluting Coronary Stents Sales Value, by Application (2019-2030)

4.2.3 Global Drug-eluting Coronary Stents Sales Value, by Application (%) (2019-2030)

4.3 Global Drug-eluting Coronary Stents Sales Volume by Application

4.3.1 Global Drug-eluting Coronary Stents Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Drug-eluting Coronary Stents Sales Volume, by Application (2019-2030)

4.3.3 Global Drug-eluting Coronary Stents Sales Volume, by Application (%) (2019-2030)

4.4 Global Drug-eluting Coronary Stents Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Drug-eluting Coronary Stents Sales Value by Region

5.1.1 Global Drug-eluting Coronary Stents Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Drug-eluting Coronary Stents Sales Value by Region (2019-2024)

5.1.3 Global Drug-eluting Coronary Stents Sales Value by Region (2025-2030)

5.1.4 Global Drug-eluting Coronary Stents Sales Value by Region (%), (2019-2030)

5.2 Global Drug-eluting Coronary Stents Sales Volume by Region

5.2.1 Global Drug-eluting Coronary Stents Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Drug-eluting Coronary Stents Sales Volume by Region (2019-2024)

5.2.3 Global Drug-eluting Coronary Stents Sales Volume by Region (2025-2030)

5.2.4 Global Drug-eluting Coronary Stents Sales Volume by Region (%), (2019-2030)

5.3 Global Drug-eluting Coronary Stents Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Drug-eluting Coronary Stents Sales Value, 2019-2030

5.4.2 North America Drug-eluting Coronary Stents Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Drug-eluting Coronary Stents Sales Value, 2019-2030

5.5.2 Europe Drug-eluting Coronary Stents Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Drug-eluting Coronary Stents Sales Value, 2019-2030

5.6.2 Asia Pacific Drug-eluting Coronary Stents Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Drug-eluting Coronary Stents Sales Value, 2019-2030

5.7.2 South America Drug-eluting Coronary Stents Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Drug-eluting Coronary Stents Sales Value, 2019-2030

5.8.2 Middle East & Africa Drug-eluting Coronary Stents Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Drug-eluting Coronary Stents Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Drug-eluting Coronary Stents Sales Value

6.2.1 Key Countries/Regions Drug-eluting Coronary Stents Sales Value, 2019-2030

6.2.2 Key Countries/Regions Drug-eluting Coronary Stents Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Drug-eluting Coronary Stents Sales Value, 2019-2030

6.3.2 United States Drug-eluting Coronary Stents Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Drug-eluting Coronary Stents Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Drug-eluting Coronary Stents Sales Value, 2019-2030

6.4.2 Europe Drug-eluting Coronary Stents Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Drug-eluting Coronary Stents Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Drug-eluting Coronary Stents Sales Value, 2019-2030

6.5.2 China Drug-eluting Coronary Stents Sales Value by Type (%), 2023 VS 2030

6.5.3 China Drug-eluting Coronary Stents Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Drug-eluting Coronary Stents Sales Value, 2019-2030

6.6.2 Japan Drug-eluting Coronary Stents Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Drug-eluting Coronary Stents Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Drug-eluting Coronary Stents Sales Value, 2019-2030

6.7.2 South Korea Drug-eluting Coronary Stents Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Drug-eluting Coronary Stents Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Drug-eluting Coronary Stents Sales Value, 2019-2030

6.8.2 Southeast Asia Drug-eluting Coronary Stents Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Drug-eluting Coronary Stents Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Drug-eluting Coronary Stents Sales Value, 2019-2030

6.9.2 India Drug-eluting Coronary Stents Sales Value by Type (%), 2023 VS 2030

6.9.3 India Drug-eluting Coronary Stents Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Medtronic

7.1.1 Medtronic Company Information

7.1.2 Medtronic Introduction and Business Overview

7.1.3 Medtronic Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Medtronic Drug-eluting Coronary Stents Product Offerings

7.1.5 Medtronic Recent Development

7.2 Boston Scientific

7.2.1 Boston Scientific Company Information

7.2.2 Boston Scientific Introduction and Business Overview

7.2.3 Boston Scientific Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Boston Scientific Drug-eluting Coronary Stents Product Offerings

7.2.5 Boston Scientific Recent Development

7.3 Biosensors

7.3.1 Biosensors Company Information

7.3.2 Biosensors Introduction and Business Overview

7.3.3 Biosensors Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Biosensors Drug-eluting Coronary Stents Product Offerings

7.3.5 Biosensors Recent Development

7.4 Terumo

7.4.1 Terumo Company Information

7.4.2 Terumo Introduction and Business Overview

7.4.3 Terumo Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Terumo Drug-eluting Coronary Stents Product Offerings

7.4.5 Terumo Recent Development

7.5 MicroPort

7.5.1 MicroPort Company Information

7.5.2 MicroPort Introduction and Business Overview

7.5.3 MicroPort Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2019-2024)

7.5.4 MicroPort Drug-eluting Coronary Stents Product Offerings

7.5.5 MicroPort Recent Development

7.6 Lepu Medical

7.6.1 Lepu Medical Company Information

7.6.2 Lepu Medical Introduction and Business Overview

7.6.3 Lepu Medical Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Lepu Medical Drug-eluting Coronary Stents Product Offerings

7.6.5 Lepu Medical Recent Development

7.7 B.Braun

7.7.1 B.Braun Company Information

7.7.2 B.Braun Introduction and Business Overview

7.7.3 B.Braun Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2019-2024)

7.7.4 B.Braun Drug-eluting Coronary Stents Product Offerings

7.7.5 B.Braun Recent Development

7.8 Atrium Medical

7.8.1 Atrium Medical Company Information

7.8.2 Atrium Medical Introduction and Business Overview

7.8.3 Atrium Medical Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Atrium Medical Drug-eluting Coronary Stents Product Offerings

7.8.5 Atrium Medical Recent Development

7.9 SINOMED

7.9.1 SINOMED Company Information

7.9.2 SINOMED Introduction and Business Overview

7.9.3 SINOMED Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2019-2024)

7.9.4 SINOMED Drug-eluting Coronary Stents Product Offerings

7.9.5 SINOMED Recent Development

7.10 LBC

7.10.1 LBC Company Information

7.10.2 LBC Introduction and Business Overview

7.10.3 LBC Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2019-2024)

7.10.4 LBC Drug-eluting Coronary Stents Product Offerings

7.10.5 LBC Recent Development

7.11 Essen Technology

7.11.1 Essen Technology Company Information

7.11.2 Essen Technology Introduction and Business Overview

7.11.3 Essen Technology Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Essen Technology Drug-eluting Coronary Stents Product Offerings

7.11.5 Essen Technology Recent Development

8 Industry Chain Analysis

8.1 Drug-eluting Coronary Stents Industrial Chain

8.2 Drug-eluting Coronary Stents Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Drug-eluting Coronary Stents Sales Model

8.5.2 Sales Channel

8.5.3 Drug-eluting Coronary Stents Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Drug-eluting Coronary Stents Market Trends

Table 2. Drug-eluting Coronary Stents Market Drivers & Opportunity

Table 3. Drug-eluting Coronary Stents Market Challenges

Table 4. Drug-eluting Coronary Stents Market Restraints

Table 5. Global Drug-eluting Coronary Stents Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Drug-eluting Coronary Stents Revenue Market Share by Company (2019-2024)

Table 7. Global Drug-eluting Coronary Stents Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Drug-eluting Coronary Stents Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Drug-eluting Coronary Stents Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Drug-eluting Coronary Stents Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Drug-eluting Coronary Stents Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Drug-eluting Coronary Stents

Table 13. Global Drug-eluting Coronary Stents Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-eluting Coronary Stents as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Drug-eluting Coronary Stents Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Drug-eluting Coronary Stents Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Drug-eluting Coronary Stents Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Drug-eluting Coronary Stents Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Drug-eluting Coronary Stents Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Drug-eluting Coronary Stents Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Drug-eluting Coronary Stents Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Drug-eluting Coronary Stents Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Drug-eluting Coronary Stents Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Drug-eluting Coronary Stents Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Drug-eluting Coronary Stents Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Drug-eluting Coronary Stents Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Drug-eluting Coronary Stents Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Drug-eluting Coronary Stents Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Drug-eluting Coronary Stents Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Drug-eluting Coronary Stents Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Drug-eluting Coronary Stents Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Drug-eluting Coronary Stents Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Drug-eluting Coronary Stents Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Drug-eluting Coronary Stents Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Drug-eluting Coronary Stents Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Drug-eluting Coronary Stents Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Drug-eluting Coronary Stents Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Drug-eluting Coronary Stents Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Drug-eluting Coronary Stents Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Drug-eluting Coronary Stents Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Drug-eluting Coronary Stents Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Drug-eluting Coronary Stents Sales Value by Region (2019-2024) & (%)

Table 44. Global Drug-eluting Coronary Stents Sales Value by Region (2025-2030) & (%)

Table 45. Global Drug-eluting Coronary Stents Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Drug-eluting Coronary Stents Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Drug-eluting Coronary Stents Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Drug-eluting Coronary Stents Sales Volume by Region (2019-2024) & (%)

Table 49. Global Drug-eluting Coronary Stents Sales Volume by Region (2025-2030) & (%)

Table 50. Global Drug-eluting Coronary Stents Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Drug-eluting Coronary Stents Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Drug-eluting Coronary Stents Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Drug-eluting Coronary Stents Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Drug-eluting Coronary Stents Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Drug-eluting Coronary Stents Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Drug-eluting Coronary Stents Sales Volume, (2025-2030) & (K Units)

Table 57. Medtronic Company Information

Table 58. Medtronic Introduction and Business Overview

Table 59. Medtronic Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Medtronic Drug-eluting Coronary Stents Product Offerings

Table 61. Medtronic Recent Development

Table 62. Boston Scientific Company Information

Table 63. Boston Scientific Introduction and Business Overview

Table 64. Boston Scientific Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Boston Scientific Drug-eluting Coronary Stents Product Offerings

Table 66. Boston Scientific Recent Development

Table 67. Biosensors Company Information

Table 68. Biosensors Introduction and Business Overview

Table 69. Biosensors Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Biosensors Drug-eluting Coronary Stents Product Offerings

Table 71. Biosensors Recent Development

Table 72. Terumo Company Information

Table 73. Terumo Introduction and Business Overview

Table 74. Terumo Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Terumo Drug-eluting Coronary Stents Product Offerings

Table 76. Terumo Recent Development

Table 77. MicroPort Company Information

Table 78. MicroPort Introduction and Business Overview

Table 79. MicroPort Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. MicroPort Drug-eluting Coronary Stents Product Offerings

Table 81. MicroPort Recent Development

Table 82. Lepu Medical Company Information

Table 83. Lepu Medical Introduction and Business Overview

Table 84. Lepu Medical Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Lepu Medical Drug-eluting Coronary Stents Product Offerings

Table 86. Lepu Medical Recent Development

Table 87. B.Braun Company Information

Table 88. B.Braun Introduction and Business Overview

Table 89. B.Braun Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. B.Braun Drug-eluting Coronary Stents Product Offerings

Table 91. B.Braun Recent Development

Table 92. Atrium Medical Company Information

Table 93. Atrium Medical Introduction and Business Overview

Table 94. Atrium Medical Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Atrium Medical Drug-eluting Coronary Stents Product Offerings

Table 96. Atrium Medical Recent Development

Table 97. SINOMED Company Information

Table 98. SINOMED Introduction and Business Overview

Table 99. SINOMED Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. SINOMED Drug-eluting Coronary Stents Product Offerings

Table 101. SINOMED Recent Development

Table 102. LBC Company Information

Table 103. LBC Introduction and Business Overview

Table 104. LBC Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. LBC Drug-eluting Coronary Stents Product Offerings

Table 106. LBC Recent Development

Table 107. Essen Technology Company Information

Table 108. Essen Technology Introduction and Business Overview

Table 109. Essen Technology Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Essen Technology Drug-eluting Coronary Stents Product Offerings

Table 111. Essen Technology Recent Development

Table 112. Key Raw Materials Lists

Table 113. Raw Materials Key Suppliers Lists

Table 114. Drug-eluting Coronary Stents Downstream Customers

Table 115. Drug-eluting Coronary Stents Distributors List

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Drug-eluting Coronary Stents Product Picture

Figure 2. Global Drug-eluting Coronary Stents Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Drug-eluting Coronary Stents Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Drug-eluting Coronary Stents Sales Volume (2019-2030) & (K Units)

Figure 5. Global Drug-eluting Coronary Stents Sales Price (2019-2030) & (US$/Unit)

Figure 6. Drug-eluting Coronary Stents Report Years Considered

Figure 7. Global Drug-eluting Coronary Stents Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Drug-eluting Coronary Stents Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Drug-eluting Coronary Stents Revenue in 2023

Figure 10. Drug-eluting Coronary Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Stent Diameter ＜4mm Picture

Figure 12. Stent Diameter ＞4mm Picture

Figure 13. Global Drug-eluting Coronary Stents Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Drug-eluting Coronary Stents Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Drug-eluting Coronary Stents Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Drug-eluting Coronary Stents Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Drug-eluting Coronary Stents Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of ASCs

Figure 19. Product Picture of Hospitals

Figure 20. Product Picture of Cardiology Center

Figure 21. Product Picture of Others

Figure 22. Global Drug-eluting Coronary Stents Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Drug-eluting Coronary Stents Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Drug-eluting Coronary Stents Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 25. Global Drug-eluting Coronary Stents Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Drug-eluting Coronary Stents Price by Application (2019-2030) & (US$/Unit)

Figure 27. North America Drug-eluting Coronary Stents Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Drug-eluting Coronary Stents Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Drug-eluting Coronary Stents Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Drug-eluting Coronary Stents Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Drug-eluting Coronary Stents Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Drug-eluting Coronary Stents Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Drug-eluting Coronary Stents Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Drug-eluting Coronary Stents Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Drug-eluting Coronary Stents Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Drug-eluting Coronary Stents Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Drug-eluting Coronary Stents Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Drug-eluting Coronary Stents Sales Volume (%), (2019-2030)

Figure 39. United States Drug-eluting Coronary Stents Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Drug-eluting Coronary Stents Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Drug-eluting Coronary Stents Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Drug-eluting Coronary Stents Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Drug-eluting Coronary Stents Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Drug-eluting Coronary Stents Sales Value by Application (%), 2023 VS 2030

Figure 45. China Drug-eluting Coronary Stents Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Drug-eluting Coronary Stents Sales Value by Type (%), 2023 VS 2030

Figure 47. China Drug-eluting Coronary Stents Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Drug-eluting Coronary Stents Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Drug-eluting Coronary Stents Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Drug-eluting Coronary Stents Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Drug-eluting Coronary Stents Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Drug-eluting Coronary Stents Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Drug-eluting Coronary Stents Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Drug-eluting Coronary Stents Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Drug-eluting Coronary Stents Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Drug-eluting Coronary Stents Sales Value by Application (%), 2023 VS 2030

Figure 57. India Drug-eluting Coronary Stents Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Drug-eluting Coronary Stents Sales Value by Type (%), 2023 VS 2030

Figure 59. India Drug-eluting Coronary Stents Sales Value by Application (%), 2023 VS 2030

Figure 60. Drug-eluting Coronary Stents Industrial Chain

Figure 61. Drug-eluting Coronary Stents Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-0M15054

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Intravascular Stent Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-34N8228

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Cardiac Surgery Radiofrequency Ablation Apparatus - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-4H14831

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-28D18419

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Drug-eluting Coronary Stents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: December 2024

Report Code: QYRE-Auto-13I12449

Drug-eluting Coronary Stents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Drug-eluting Coronary Stents - Market Size

Drug-eluting Coronary Stents - Market

Report Scope

Scope of Drug-eluting Coronary Stents - Market Report

Chapter Outline

FAQ for this report

What is the Drug-eluting Coronary Stents - Market size in 2030?

Who are the main players in the Drug-eluting Coronary Stents - Market report?

What are the Application segmentation covered in the Drug-eluting Coronary Stents - Market report?

What are the Type segmentation covered in the Drug-eluting Coronary Stents - Market report?

FEATURED COMPANIES

RELATED REPORTS